Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC
Go back to Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC| Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) | Delayed: 101.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.94 | 52 Week High | $101.99 | |||
| Open | $3.23 | 52 Week Low | $58.50 | |||
| Day High | $101.94 | P/E | N/A | |||
| Day Low | $101.94 | EPS | $-0.27 | |||
| Volume | 3,714 | |||||
| Hospira Inc. (NYSE: HSP) | Delayed: 89.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.95 | 52 Week High | $90.63 | |||
| Open | $3.49 | 52 Week Low | $46.56 | |||
| Day High | $89.95 | P/E | N/A | |||
| Day Low | $89.95 | EPS | $-0.05 | |||
| Volume | 24,251 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.84 +0.29 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.55 | 52 Week High | $65.46 | |||
| Open | $134.43 | 52 Week Low | $47.97 | |||
| Day High | $135.97 | P/E | 92.41 | |||
| Day Low | $133.40 | EPS | $1.47 | |||
| Volume | 6,868,318 | |||||

